Photo by alinnnaaaa from unsplash
Nusinersen (Spinraza) is a recently approved drug for treating spinal muscular atrophy. Approval of nusinersen may signal new opportunities for using antisense oligonucleotides as treatments for devastating neurological diseases. Click to show full abstract
Nusinersen (Spinraza) is a recently approved drug for treating spinal muscular atrophy. Approval of nusinersen may signal new opportunities for using antisense oligonucleotides as treatments for devastating neurological diseases.
Keywords:
spinal muscular;
drug;
antisense oligonucleotide;
nusinersen antisense;
muscular atrophy
Journal Title: Nature Neuroscience
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Nature Neuroscience
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!